The Erdheim-Chester Disease Global Alliance (ECDGA) is proud to share that our Medical Advisory Board member, Dr. Oshrat Hershkovitz-Rokah, will co-present a pivotal educational session at the 2025 European Hematology Association (EHA) Congress. This special #ASH–#EHA collaborative session will focus on Langerhans Cell Histiocytosis (LCH) and Other Histiocytic Neoplasms—an area of immense importance for the rare disease community.
Dr. Hershkovitz-Rokah will be joined by Dr. Carl Allen, a leading expert in the field, for a joint presentation that promises deep insight into these rare and complex conditions, including Erdheim-Chester Disease (ECD), Rosai-Dorfman Disease (RDD), and others within the histiocytosis family.
Session Title: LCH and Other Histiocytic Neoplasms
Date: Friday, June 13, 2025
Time: 15:45
Location: Room Coral 6
This is an exceptional opportunity for medical professionals, researchers, and advocates to expand their understanding of diseases that are often underrecognized and difficult to diagnose. With growing research, improved diagnostics, and evolving treatment options, collaborative education is key to progress.
Dr. Hershkovitz-Rokah’s involvement reflects ECDGA’s continued commitment to supporting cutting-edge research and medical education in rare histiocytic disorders. We are honored to see our advisors helping lead these global conversations.
Rare. Complex. Insightful.
Don’t miss this opportunity to learn from the best.
Visit https://ehaweb.org/connect-network/eha2025-congress to learn more.
Disclaimer:
The Erdheim-Chester Disease Global Alliance (ECDGA) does not provide medical advice, diagnoses, or treatments. All content is for informational purposes only. Please consult with a healthcare provider for medical concerns.